Loestrin 24 FE Antitrust Litigation

  1. July 16, 2019

    Loestrin Buyers Seek Approval Of $1M Lupin Deal

    Loestrin end payors on Monday moved for preliminary approval of their $1 million settlement with Lupin Pharmaceuticals to resolve their portion of litigation accusing the company of working with another pharmaceutical duo to sideline generic alternatives to the widely used birth control drug.

  2. July 11, 2019

    Loestrin Buyers Fight To Advance Antitrust Case To Trial

    Loestrin purchasers accusing Warner Chilcott and Watson Pharmaceuticals of sidelining generic alternatives to the widely used birth control drug have shot back at the drugmakers' efforts to slip their antitrust lawsuit, as the buyers insisted there are still too many questions unanswered to stop the case now.

  3. May 20, 2019

    Drugmaker, Retailers Strike Deal In Loestrin Antitrust MDL

    Lupin Pharmaceuticals cut a deal that will allow it to escape antitrust claims leveled against it by Walgreens, CVS and other retailers that it conspired with two other pharmaceutical companies to keep generic versions of birth control drug Loestrin off the market.

  4. October 26, 2018

    Only Loestrin Market Matters In Antitrust Row, Retailers Say

    Warner Chilcott can't avoid antitrust litigation over sales of its birth control medication Loestrin 24 by claiming it shares the market with all available oral birth control, as the allegations in the suit are much narrower and focus on generic competition, retailers told a Rhode Island federal court in a filing made public Friday.

  5. August 21, 2017

    Warner Chilcott Must Face Loestrin Pay-For-Delay MDL

    Warner Chilcott Co. LLC, Watson Pharmaceuticals Inc. and Lupin Pharmaceuticals Inc. must face multidistrict litigation accusing them of entering into illegal reverse-payment deals to keep a generic of the birth control medication Loestrin off the market, according to an opinion unsealed Monday in Rhode Island federal court.

  6. March 16, 2017

    Warner Chilcott Wins Discovery In Loestrin Pay-For-Delay MDL

    A Rhode Island federal judge on Wednesday granted a discovery bid by Warner Chilcott PLC and others in multidistrict litigation over alleged pay-for-delay settlements for the contraceptive Loestrin, as they look to gather information from a group of pharmacy buyers to determine whether they were able to sell alternatives to Loestrin to patients.

  7. January 17, 2017

    Drug Cos. Aim To Force Market Discovery In Loestrin MDL

    Warner Chilcott PLC and other defendants in multidistrict litigation challenging alleged pay-for-delay settlements over contraceptive Loestrin moved Friday in Rhode Island federal court to force a group of buyers to give up information that may shed light on whether the drug is a market unto itself.

  8. August 23, 2016

    Warner Says Aggrenox Court Erred In Pay-For-Delay Case

    Warner Chilcott PLC told a Rhode Island federal court Monday that a recent ruling in a pay-for-delay suit over blood-clot medication Aggrenox was erroneous and should not be followed in its own multidistrict litigation concerning the contraceptive Loestrin.

  9. July 18, 2016

    Warner Chilcott Can't Nix Pay-For-Delay Row: Loestrin Buyers

    Warner Chilcott PLC should not be allowed to duck pay-for-delay multidistrict litigation concerning the contraceptive pill Loestrin, as amended claims concerning the allegations were properly filed, direct and indirect purchasers told the Rhode Island federal court in separate filings on Friday.

  10. July 15, 2016

    Retailers Say Birth-Control Drugmaker Stifled Generics

    Retailers accusing drugmakers of conspiring to keep generic versions of the birth control pill Loestrin 24 off the market urged the Rhode Island federal judge overseeing the multidistrict litigation to keep their claims alive, saying they consist of specific allegations of anti-competitive behavior that can't be ignored.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!